首页 > 最新文献

Zentralblatt fur Gynakologie最新文献

英文 中文
[Gastric cancer in pregnancy -- a case report]. 【妊娠期胃癌1例报告】。
Pub Date : 2006-08-01 DOI: 10.1055/s-2006-933429
D Brüggmann, M K Bohlmann, R M Bohle, H-R Tinneberg

Nausea and vomiting are common sufferings of pregnant woman. No gynaecologist would consider carcinoma of the stomach as a probable differential diagnosis according the extremely rare probability of this disease during pregnancy. Consequently, a late diagnosis in pregnancy can result in spreading throughout the whole abdomen. In this advanced stage, it is only possible to recommend palliative care to the patient followed by short survival. Fetal metastasis is a rare entity, therefore caesarean section and chemotherapy should not be performed until fetal maturity. If vomiting and nausea are prolonged after the sixteenth week of pregnancy a malignant disease of the stomach should be excluded. Only in case of short delay between symptoms and diagnosis, the stomach cancer can be resected totally followed by a better overall survival of the patient.

恶心和呕吐是孕妇的常见病。没有妇科医生会考虑胃癌作为一个可能的鉴别诊断,因为这种疾病在怀孕期间的概率非常低。因此,妊娠晚期诊断可导致整个腹部扩散。在这个晚期阶段,只有可能推荐姑息治疗患者随后的短期生存。胎儿转移是一个罕见的实体,因此剖腹产和化疗不应进行,直到胎儿成熟。如果妊娠第16周后持续呕吐和恶心,应排除胃部恶性疾病。只有在症状和诊断之间延迟较短的情况下,才能完全切除胃癌,从而提高患者的总生存率。
{"title":"[Gastric cancer in pregnancy -- a case report].","authors":"D Brüggmann,&nbsp;M K Bohlmann,&nbsp;R M Bohle,&nbsp;H-R Tinneberg","doi":"10.1055/s-2006-933429","DOIUrl":"https://doi.org/10.1055/s-2006-933429","url":null,"abstract":"<p><p>Nausea and vomiting are common sufferings of pregnant woman. No gynaecologist would consider carcinoma of the stomach as a probable differential diagnosis according the extremely rare probability of this disease during pregnancy. Consequently, a late diagnosis in pregnancy can result in spreading throughout the whole abdomen. In this advanced stage, it is only possible to recommend palliative care to the patient followed by short survival. Fetal metastasis is a rare entity, therefore caesarean section and chemotherapy should not be performed until fetal maturity. If vomiting and nausea are prolonged after the sixteenth week of pregnancy a malignant disease of the stomach should be excluded. Only in case of short delay between symptoms and diagnosis, the stomach cancer can be resected totally followed by a better overall survival of the patient.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 4","pages":"224-8"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2006-933429","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26141702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
[Management of abnormal uterine bleeding]. 子宫异常出血的处理。
Pub Date : 2006-08-01 DOI: 10.1055/s-2006-933448
R Gaetje, A Scharl, M Kaufmann, A Ahr

Bleeding disorders are one of the most frequent gynecological problems. The causes of bleeding disorders, and their frequency in particular, vary depending on the age of the woman affected. In premenopause and perimenopause, the most frequent causes are hormonal, in up to 90 % of cases, as well as organic changes in the uterus such as myomas, adenomyosis uteri, or endometrial polyps, in up to 70 % of cases. Coagulation defects cause increased bleeding, particularly in girls and young women, with no other recognizable cause. The treatment of bleeding disorders is causally based, although if the woman does not wish to have children, the therapeutic algorithm in many cases leads to similar symptomatic measures. The following therapeutic approaches, listed in order of increasing efficacy, are mainly used in the treatment of increased bleeding: gestagen, estrogen-gestagen combination, levonorgestrel (Mirena) and endometrial ablation or myoma enucleation, with comparable success rates, and finally hysterectomy. Embolization of the uterine artery in myomas or adenomyosis uteri, nonsteroidal anti-inflammatory drugs, and antifibrinolytic agents represent alternatives that may be useful in individual cases. The paper provides an overview of the various causes, useful diagnostic measures, and treatment options in uterine bleeding disorders.

出血性疾病是最常见的妇科问题之一。出血性疾病的原因,特别是其频率,因受影响妇女的年龄而异。在绝经前和围绝经期,最常见的原因是激素,高达90%的病例,以及子宫的器质性变化,如肌瘤、子宫腺肌病或子宫内膜息肉,高达70%的病例。凝血缺陷导致出血增加,特别是在女孩和年轻妇女中,没有其他可识别的原因。出血性疾病的治疗是基于因果关系的,尽管如果妇女不想生孩子,治疗算法在许多情况下会导致类似的症状措施。以下治疗方法主要用于治疗出血增多:孕激素、雌激素-孕激素联合、左炔诺孕酮(mrena)联合子宫内膜消融或肌瘤去核,成功率相当,最后是子宫切除术。子宫肌瘤或子宫腺肌病的子宫动脉栓塞、非甾体类抗炎药和抗纤溶药物可能是个别病例中有用的替代方案。本文提供了一个概述的各种原因,有用的诊断措施,并在子宫出血障碍的治疗方案。
{"title":"[Management of abnormal uterine bleeding].","authors":"R Gaetje,&nbsp;A Scharl,&nbsp;M Kaufmann,&nbsp;A Ahr","doi":"10.1055/s-2006-933448","DOIUrl":"https://doi.org/10.1055/s-2006-933448","url":null,"abstract":"<p><p>Bleeding disorders are one of the most frequent gynecological problems. The causes of bleeding disorders, and their frequency in particular, vary depending on the age of the woman affected. In premenopause and perimenopause, the most frequent causes are hormonal, in up to 90 % of cases, as well as organic changes in the uterus such as myomas, adenomyosis uteri, or endometrial polyps, in up to 70 % of cases. Coagulation defects cause increased bleeding, particularly in girls and young women, with no other recognizable cause. The treatment of bleeding disorders is causally based, although if the woman does not wish to have children, the therapeutic algorithm in many cases leads to similar symptomatic measures. The following therapeutic approaches, listed in order of increasing efficacy, are mainly used in the treatment of increased bleeding: gestagen, estrogen-gestagen combination, levonorgestrel (Mirena) and endometrial ablation or myoma enucleation, with comparable success rates, and finally hysterectomy. Embolization of the uterine artery in myomas or adenomyosis uteri, nonsteroidal anti-inflammatory drugs, and antifibrinolytic agents represent alternatives that may be useful in individual cases. The paper provides an overview of the various causes, useful diagnostic measures, and treatment options in uterine bleeding disorders.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 4","pages":"196-201"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2006-933448","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26141697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Gynecological outpatient management in HNPCC]. [妇科门诊管理]。
Pub Date : 2006-08-01 DOI: 10.1055/s-2006-933430
K Bach, J Preyer, A Jensen, J T Epplen, E Kunstmann

Objective: Female patients with diagnosis of endometrial or ovarian cancer before the age of 45 are suspicious of hereditary non-polyposis colorectal cancer (HNPCC). In the daily routine it is difficult to distinguish between HNPCC and sporadic cancer, however, the consequences are severe. A standardised interview was conducted to evaluate the management of HNPCC-patients in medical practice. COHORT AND METHODS: 36 gynecologists working in medical practice were interviewed, statistical analyses were performed with SPSS 12.0.

Results: Most of the gynecologists refer to a hereditary tumor syndrome in consideration of family history, diagnosis at early age and synchronous or metachronous cancer. Patients with endometrial or ovarian cancer before the age of 45 years were rated as high risk patients. 72 % of the gynecologists take care of female patients suspicious of HNPCC according to the Bethesda criteria, even though half of these do not consider that diagnosis. Gynecological surveillance examinations are not fully taken into account. The interdisciplinary surveillance concept is rarely initiated.

Conclusion: The current surveillance recommendation for patients suspicious of HNPCC should be applied more often in the daily routine of gynecological outpatient management. Sponsored by Deutsche Krebshilfe.

目的:45岁前诊断为子宫内膜癌或卵巢癌的女性患者有可能罹患遗传性非息肉性结直肠癌(HNPCC)。在日常生活中,很难区分HNPCC和散发性癌症,然而,后果是严重的。采用标准化访谈法对医疗实践中对hnpcc患者的管理进行评价。队列与方法:对36名在职妇科医生进行访谈,采用SPSS 12.0软件进行统计分析。结果:妇科医生在考虑家族史、早期诊断及同时或异时性肿瘤时,以遗传性肿瘤综合征居多。45岁以前患有子宫内膜癌或卵巢癌的患者被列为高危患者。根据Bethesda标准,72%的妇科医生会照顾怀疑患有HNPCC的女性患者,尽管其中一半的人不考虑这种诊断。没有充分考虑妇科监测检查。跨学科监测的概念很少被提出。结论:在妇科门诊的日常管理中,应更多地应用目前推荐的对疑似HNPCC患者的监测。由德意志银行赞助。
{"title":"[Gynecological outpatient management in HNPCC].","authors":"K Bach,&nbsp;J Preyer,&nbsp;A Jensen,&nbsp;J T Epplen,&nbsp;E Kunstmann","doi":"10.1055/s-2006-933430","DOIUrl":"https://doi.org/10.1055/s-2006-933430","url":null,"abstract":"<p><strong>Objective: </strong>Female patients with diagnosis of endometrial or ovarian cancer before the age of 45 are suspicious of hereditary non-polyposis colorectal cancer (HNPCC). In the daily routine it is difficult to distinguish between HNPCC and sporadic cancer, however, the consequences are severe. A standardised interview was conducted to evaluate the management of HNPCC-patients in medical practice. COHORT AND METHODS: 36 gynecologists working in medical practice were interviewed, statistical analyses were performed with SPSS 12.0.</p><p><strong>Results: </strong>Most of the gynecologists refer to a hereditary tumor syndrome in consideration of family history, diagnosis at early age and synchronous or metachronous cancer. Patients with endometrial or ovarian cancer before the age of 45 years were rated as high risk patients. 72 % of the gynecologists take care of female patients suspicious of HNPCC according to the Bethesda criteria, even though half of these do not consider that diagnosis. Gynecological surveillance examinations are not fully taken into account. The interdisciplinary surveillance concept is rarely initiated.</p><p><strong>Conclusion: </strong>The current surveillance recommendation for patients suspicious of HNPCC should be applied more often in the daily routine of gynecological outpatient management. Sponsored by Deutsche Krebshilfe.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 4","pages":"207-12"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2006-933430","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26141699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Vaginal delivery after caesarean section: a propective study of 146 cases. 146例剖宫产后阴道分娩的前瞻性研究。
Pub Date : 2006-08-01 DOI: 10.1055/s-2005-836756
L Kouam, D C Nkemayim, I Nsangou, P M Tebeu, A S Doh

We report on a series of 146 cases of vaginal delivery after previous Caesarean section conducted between 1993 and 2002 at the University Teaching Hospital, Yaounde (Cameroon). During the period under review 945 cases of Caesarean section were done out of a total of 9 439 deliveries (10 %). Delivery was spontaneous in 141 cases whereas in 5 cases it was assisted by vacuum extraction. In 13 cases Caesarean section was carried out after failure of trial of labour. Maternal mortality, resulting from pulmonary embolism, was observed in 1 case. We conclude that strict selection of patients who had previous Caesarean section for trial of labour renders vaginal delivery a safe alternative to Caesarean section.

我们报告了1993年至2002年期间在雅温得(喀麦隆)大学教学医院进行的剖腹产术后阴道分娩的146例病例。在本报告所述期间,在总共9 439例分娩中,进行了945例剖腹产手术(10%)。141例自然分娩,5例辅助抽吸分娩。13例经试产失败后行剖宫产。产妇因肺栓塞死亡1例。我们得出的结论是,严格选择以前剖腹产的患者进行分娩试验,使阴道分娩成为剖腹产的安全选择。
{"title":"Vaginal delivery after caesarean section: a propective study of 146 cases.","authors":"L Kouam,&nbsp;D C Nkemayim,&nbsp;I Nsangou,&nbsp;P M Tebeu,&nbsp;A S Doh","doi":"10.1055/s-2005-836756","DOIUrl":"https://doi.org/10.1055/s-2005-836756","url":null,"abstract":"<p><p>We report on a series of 146 cases of vaginal delivery after previous Caesarean section conducted between 1993 and 2002 at the University Teaching Hospital, Yaounde (Cameroon). During the period under review 945 cases of Caesarean section were done out of a total of 9 439 deliveries (10 %). Delivery was spontaneous in 141 cases whereas in 5 cases it was assisted by vacuum extraction. In 13 cases Caesarean section was carried out after failure of trial of labour. Maternal mortality, resulting from pulmonary embolism, was observed in 1 case. We conclude that strict selection of patients who had previous Caesarean section for trial of labour renders vaginal delivery a safe alternative to Caesarean section.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 4","pages":"213-6"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2005-836756","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26141700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Case report -- needle in the breast]. 【病例报告——针扎进乳房】。
Pub Date : 2006-08-01 DOI: 10.1055/s-2006-933487
C Solbach, T Diebold, F Louwen, M Kaufmann

A case of a 23-year-old, foreign language speaking patient is reported, who presented herself in our out-patient clinic with stitching pain in the upper left quadrant of her left breast. Not until the third appointment and intensive questioning, leading to more detailed informations about the medical history, it was possible to diagnose a sewing needle in the breast by mammography. Neither clinical signs nor several ultrasound examinations lead to the diagnosis before.

我们报告一例23岁,说外语的病人,因左乳房左上象限缝合性疼痛来到我们的门诊。直到第三次预约和密集的询问,获得了关于病史的更详细信息,才有可能通过乳房x光检查诊断出乳房上的缝衣针。之前的临床症状和多次超声检查都无法诊断。
{"title":"[Case report -- needle in the breast].","authors":"C Solbach,&nbsp;T Diebold,&nbsp;F Louwen,&nbsp;M Kaufmann","doi":"10.1055/s-2006-933487","DOIUrl":"https://doi.org/10.1055/s-2006-933487","url":null,"abstract":"<p><p>A case of a 23-year-old, foreign language speaking patient is reported, who presented herself in our out-patient clinic with stitching pain in the upper left quadrant of her left breast. Not until the third appointment and intensive questioning, leading to more detailed informations about the medical history, it was possible to diagnose a sewing needle in the breast by mammography. Neither clinical signs nor several ultrasound examinations lead to the diagnosis before.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 4","pages":"229-31"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2006-933487","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26141703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
[Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers]. [老年人预防三种主要癌症的机会和风险:乳腺癌、前列腺癌和结肠直肠癌]。
Pub Date : 2006-06-01 DOI: 10.1055/s-2006-933372
G F Kolb

The big three, breast cancer (BC), prostate cancer (PC) and colorectal carcinoma are the most frequent malignancies world wide and also typical tumors of advanced age. Therefore the question to screen and how to screen for these tumors in the elderly is the main question for reduction of the total cancer burden and mortality in all western countries. BREAST CANCER (BC): The age related risk of BC increases from 1 : 2,500 at age 30+ to > 1 : 10 at age 80. Nevertheless, most of the national BC-Screening-Programs stop at age 60 or earlier. Therefore the majority of all advanced i. e. T (4) stages of BC are found in women age > 60. Frequently it is suggested that age related comorbidity should eliminate the benefit of treatment. Recently two longitudinal studies have clearly shown that correct standard treatment is as effective in elderly as in younger individuals. Mammography (MG) has been shown to reduce mortality of BC significantly with best results for specificity and sensitivity at age 70+. PROSTATE CANCER (PC): The screening situation of PC is quite different to BC, because risk profiles are poorly defined and the benefit of radical prostatectomy is not clearly demonstrated in the early non symptomatic stages of PC. At the other side watchful waiting leads to an elevated frequency of incontinence and enuresis as well. Two studies are now under progress and may possibly change the situation; but the final results are expected 2005-2008 at the earliest. Therefore an assisted individual decision making is the only recommendation at this time. COLORECTAL CANCER (CC): Risk groups are clearly defined. Risk of the elderly (> 60) is the average risk. The incidence increases from < 50/10 (5) to more than 500 at age 75+(male) and 500 (female). When to start and when to stop screening? Experts give the advice to begin at age 50 and to end at age 80; but this is not really evidence based. There are several unanswered questions and open problems: we are not exactly informed about complication rates of colonoscopy during the screening programs. There is a lack of data according accuracy of barium enema, virtual colonoscopy and genetic stool test in comparison to colonoscopy in combination with fecal occult blood test (FOBT). And adherence to screening is not well documented among informed patients. However, effectiveness of CC-screening (FOBT alone or in combination with colonoscopy) has been documented in three high randomised trials which have shown a disease specific mortality reduction of 15-33 % over a period of 8-13 years. But it must be clear that the economic resources must be mobilised individually or by insurance: offering the testing of only FOBT for ten years to one thousand persons can save one life.

乳腺癌(BC)、前列腺癌(PC)和结直肠癌是世界范围内最常见的恶性肿瘤,也是典型的高龄肿瘤。因此,在所有西方国家中,筛查和如何筛查老年人的这些肿瘤是减少癌症总负担和死亡率的主要问题。乳腺癌(BC):乳腺癌的年龄相关风险从30岁时的1:25 00增加到80岁时的1:10。然而,大多数国家bc筛查项目在60岁或更早时停止。因此,大多数晚期(如T(4)期)BC发生在60岁以上的女性。通常认为,年龄相关的合并症应该消除治疗的好处。最近的两项纵向研究清楚地表明,正确的标准治疗对老年人和年轻人同样有效。乳房x光检查(MG)已被证明可以显著降低BC的死亡率,在70岁以上的人群中,其特异性和敏感性效果最好。前列腺癌(PC):前列腺癌的筛查情况与BC有很大不同,因为前列腺癌的风险特征定义不清,根治性前列腺切除术的益处在前列腺癌的早期无症状阶段没有明确显示。另一方面,警惕的等待也会导致尿失禁和遗尿的频率升高。目前正在进行的两项研究可能会改变这种情况;但最终结果预计最早要到2005-2008年。因此,辅助个人决策是目前唯一的建议。结直肠癌(CC):危险人群有明确的定义。老年人(> 60岁)的风险为平均风险。发病率从< 50/10(5)增加到75岁以上的500(男性)和500(女性)。何时开始筛查,何时停止筛查?专家建议从50岁开始,到80岁结束;但这并不是基于证据的。有几个未解决的问题和悬而未决的问题:我们没有确切地了解结肠镜检查在筛查过程中的并发症发生率。钡灌肠、虚拟结肠镜和遗传粪便检查与结肠镜联合粪便潜血检查(FOBT)的准确性比较缺乏数据。在知情的患者中,对筛查的依从性没有很好的记录。然而,cc筛查(单独FOBT或与结肠镜检查联合)的有效性已在三个高度随机试验中得到证实,这些试验显示,在8-13年期间,疾病特异性死亡率降低了15- 33%。但是必须明确的是,必须单独或通过保险来调动经济资源:仅向一千人提供十年的FOBT测试可以挽救一条生命。
{"title":"[Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].","authors":"G F Kolb","doi":"10.1055/s-2006-933372","DOIUrl":"https://doi.org/10.1055/s-2006-933372","url":null,"abstract":"<p><p>The big three, breast cancer (BC), prostate cancer (PC) and colorectal carcinoma are the most frequent malignancies world wide and also typical tumors of advanced age. Therefore the question to screen and how to screen for these tumors in the elderly is the main question for reduction of the total cancer burden and mortality in all western countries. BREAST CANCER (BC): The age related risk of BC increases from 1 : 2,500 at age 30+ to > 1 : 10 at age 80. Nevertheless, most of the national BC-Screening-Programs stop at age 60 or earlier. Therefore the majority of all advanced i. e. T (4) stages of BC are found in women age > 60. Frequently it is suggested that age related comorbidity should eliminate the benefit of treatment. Recently two longitudinal studies have clearly shown that correct standard treatment is as effective in elderly as in younger individuals. Mammography (MG) has been shown to reduce mortality of BC significantly with best results for specificity and sensitivity at age 70+. PROSTATE CANCER (PC): The screening situation of PC is quite different to BC, because risk profiles are poorly defined and the benefit of radical prostatectomy is not clearly demonstrated in the early non symptomatic stages of PC. At the other side watchful waiting leads to an elevated frequency of incontinence and enuresis as well. Two studies are now under progress and may possibly change the situation; but the final results are expected 2005-2008 at the earliest. Therefore an assisted individual decision making is the only recommendation at this time. COLORECTAL CANCER (CC): Risk groups are clearly defined. Risk of the elderly (> 60) is the average risk. The incidence increases from < 50/10 (5) to more than 500 at age 75+(male) and 500 (female). When to start and when to stop screening? Experts give the advice to begin at age 50 and to end at age 80; but this is not really evidence based. There are several unanswered questions and open problems: we are not exactly informed about complication rates of colonoscopy during the screening programs. There is a lack of data according accuracy of barium enema, virtual colonoscopy and genetic stool test in comparison to colonoscopy in combination with fecal occult blood test (FOBT). And adherence to screening is not well documented among informed patients. However, effectiveness of CC-screening (FOBT alone or in combination with colonoscopy) has been documented in three high randomised trials which have shown a disease specific mortality reduction of 15-33 % over a period of 8-13 years. But it must be clear that the economic resources must be mobilised individually or by insurance: offering the testing of only FOBT for ten years to one thousand persons can save one life.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 3","pages":"123-8"},"PeriodicalIF":0.0,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2006-933372","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26074048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
[Ernst Wertheim, or the significance of the EBM of the cervical cancer]. [Ernst Wertheim,或EBM对宫颈癌的意义]。
Pub Date : 2006-06-01 DOI: 10.1055/s-2006-921569
S Leodolter

In the field of gynecologic oncology, the beginning of the 20(th) century was dominated by a dispute between Wertheim and Schauta over the best surgical approach for cervical cancer in general, and the role of lymphonodectomy in particular. Since that time, important progress has been made with respect to diagnosis and therapy. This refers a) to the inclusion of patients with malignant diseases into clinical studies with the subsequent design and development of evidence based therapy strategies and b) on the important role of endoscopic techniques in gynecologic oncology. Some of the controversies of the "Wertheim/Schauta" era such as the "lymph node problem" are not fully resolved to date. The future will be most likely not based on diagnosis and therapy of cervical cancer, but on primary prevention with the introduction of a potent vaccination against HPV, which will be commercially available soon.

在妇科肿瘤学领域,20世纪初,Wertheim和Schauta对宫颈癌的最佳手术方式,特别是淋巴切除术的作用的争论占据了主导地位。从那时起,在诊断和治疗方面取得了重要进展。这是指a)将恶性疾病患者纳入临床研究,并随后设计和开发基于证据的治疗策略;b)内镜技术在妇科肿瘤学中的重要作用。“Wertheim/Schauta”时代的一些争议,如“淋巴结问题”,至今仍未完全解决。未来很可能不是基于宫颈癌的诊断和治疗,而是基于初级预防,引入针对HPV的强效疫苗,这种疫苗很快就会上市。
{"title":"[Ernst Wertheim, or the significance of the EBM of the cervical cancer].","authors":"S Leodolter","doi":"10.1055/s-2006-921569","DOIUrl":"https://doi.org/10.1055/s-2006-921569","url":null,"abstract":"<p><p>In the field of gynecologic oncology, the beginning of the 20(th) century was dominated by a dispute between Wertheim and Schauta over the best surgical approach for cervical cancer in general, and the role of lymphonodectomy in particular. Since that time, important progress has been made with respect to diagnosis and therapy. This refers a) to the inclusion of patients with malignant diseases into clinical studies with the subsequent design and development of evidence based therapy strategies and b) on the important role of endoscopic techniques in gynecologic oncology. Some of the controversies of the \"Wertheim/Schauta\" era such as the \"lymph node problem\" are not fully resolved to date. The future will be most likely not based on diagnosis and therapy of cervical cancer, but on primary prevention with the introduction of a potent vaccination against HPV, which will be commercially available soon.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 3","pages":"97-103"},"PeriodicalIF":0.0,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2006-921569","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26074043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
[Obstetrical care in the future -- expertise and structure]. 【未来的产科护理——专业知识和结构】。
Pub Date : 2006-06-01 DOI: 10.1055/s-2006-933511
J W Dudenhausen

The hospital remuneration act, the call for minimum amount regulations and the necessities of the specialization education rules will lead to considerable changes in obstetrical care in Germany in the future. It will develop into a two-stage structure in which the level I care takes place in houses with more than 700 deliveries and the maximum care with more than 1,500 deliveries (perinatal centres).

《医院薪酬法》、《最低金额条例》的呼吁以及《专业教育规则》的必要性将导致德国产科护理在未来发生重大变化。它将发展成一个两阶段的结构,其中一级护理在分娩700次以上的房屋进行,最高护理在分娩1500次以上的房屋(围产期中心)进行。
{"title":"[Obstetrical care in the future -- expertise and structure].","authors":"J W Dudenhausen","doi":"10.1055/s-2006-933511","DOIUrl":"https://doi.org/10.1055/s-2006-933511","url":null,"abstract":"<p><p>The hospital remuneration act, the call for minimum amount regulations and the necessities of the specialization education rules will lead to considerable changes in obstetrical care in Germany in the future. It will develop into a two-stage structure in which the level I care takes place in houses with more than 700 deliveries and the maximum care with more than 1,500 deliveries (perinatal centres).</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 3","pages":"113-6"},"PeriodicalIF":0.0,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2006-933511","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26074045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
[Identification of preeclampsia by cDNA-gene expression profiling in human placentas and serum -- a pilot study]. [通过人胎盘和血清中dna基因表达谱鉴定子痫前期-一项初步研究]。
Pub Date : 2006-06-01 DOI: 10.1055/s-2006-933377
A Ahr, U Holtrich, T Karn, A Reitter, A Rody, M Kaufmann, R Gätje

Objective: Preeclampsia is associated with significant maternal and fetal morbidity and mortality. The etiology remains unclear. For the accurate diagnosis and the prevention of preeclampsia it seems to be important to find a diagnostic tool that identifies risk patients before symptoms occur. With a new approach, the cDNA-Array analysis, human placentas and blood from preeclamptic and healthy pregnant women were examined for differentially expressed genes to find typical genes expression profiles.

Material and methods: In this pilot study, cDNA array analysis with a 19 200 gene array of placenta and blood samples from three preeclamptic patients have been performed to classify this samples based on expression patterns.

Results: Comparing normal placenta and blood from healthy delivered women (n = 4), a subset of 200 genes repeatedly found to be differentially expressed in preeclampsia. The placenta and blood samples from preeclampsia were accurately grouped by their individual gene expression patterns.

Conclusions: These results suggest that the use of cDNA array is a tool to identify gene expression patterns in preeclampsia. With this set of differentially expressed genes in conjunction with sample clustering algorithms the identification of preeclampsia in placenta or blood samples is possible.

目的:先兆子痫与显著的母婴发病率和死亡率相关。病因尚不清楚。为了准确诊断和预防先兆子痫,在症状出现之前找到一种诊断工具来识别风险患者似乎很重要。采用一种新的方法,dna - array分析,检测人类胎盘和来自子痫前期和健康孕妇的血液中的差异表达基因,以找到典型的基因表达谱。材料与方法:对3例子痫前期患者的胎盘和血液样本进行19200个基因序列的cDNA阵列分析,根据表达模式对这些样本进行分类。结果:比较正常胎盘和健康分娩妇女的血液(n = 4),反复发现200个基因子集在子痫前期存在差异表达。胎盘和子痫前期的血液样本根据其个体基因表达模式准确分组。结论:这些结果表明,cDNA阵列是一种鉴定子痫前期基因表达模式的工具。这组差异表达基因与样本聚类算法相结合,可以在胎盘或血液样本中识别子痫前期。
{"title":"[Identification of preeclampsia by cDNA-gene expression profiling in human placentas and serum -- a pilot study].","authors":"A Ahr,&nbsp;U Holtrich,&nbsp;T Karn,&nbsp;A Reitter,&nbsp;A Rody,&nbsp;M Kaufmann,&nbsp;R Gätje","doi":"10.1055/s-2006-933377","DOIUrl":"https://doi.org/10.1055/s-2006-933377","url":null,"abstract":"<p><strong>Objective: </strong>Preeclampsia is associated with significant maternal and fetal morbidity and mortality. The etiology remains unclear. For the accurate diagnosis and the prevention of preeclampsia it seems to be important to find a diagnostic tool that identifies risk patients before symptoms occur. With a new approach, the cDNA-Array analysis, human placentas and blood from preeclamptic and healthy pregnant women were examined for differentially expressed genes to find typical genes expression profiles.</p><p><strong>Material and methods: </strong>In this pilot study, cDNA array analysis with a 19 200 gene array of placenta and blood samples from three preeclamptic patients have been performed to classify this samples based on expression patterns.</p><p><strong>Results: </strong>Comparing normal placenta and blood from healthy delivered women (n = 4), a subset of 200 genes repeatedly found to be differentially expressed in preeclampsia. The placenta and blood samples from preeclampsia were accurately grouped by their individual gene expression patterns.</p><p><strong>Conclusions: </strong>These results suggest that the use of cDNA array is a tool to identify gene expression patterns in preeclampsia. With this set of differentially expressed genes in conjunction with sample clustering algorithms the identification of preeclampsia in placenta or blood samples is possible.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 3","pages":"138-42"},"PeriodicalIF":0.0,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2006-933377","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26073952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
[Massive adenomyosis in a patient with uterus septus completus]. 【完全性子宫隔患者的巨大子宫腺肌病】。
Pub Date : 2006-06-01 DOI: 10.1055/s-2005-836818
T Hansen, S Wulgaris, W Siggelkow, H Kölbl, C J Kirkpatrick

Septate uterus is a malformation caused by the defective resorption of the Müllerian ducts. It may be incomplete, or -- less frequently -- complete. We present a case of a uterus septus completus with special emphasis on the endometrial changes. We describe a 46-year-old female patient (nullipara) with a known uterus septus suffering from hypermenorrhea. Sonography demonstrated a massively enlarged uterus with several nodes. Hysterectomy was performed and tissue specimens were routinely processed. Macroscopical examination revealed a 1 230 g-weight uterus septus completus. In particular, the myometrium was enlarged and exhibited a cystic cut surface with several nodes measuring up to 4.5 cm. Histologically, we found prominent adenomyosis with several leiomyomas. Patients with uterine malformations are known to suffer from endometrial dysfunction, most commonly due to endometriosis. However, massive adenomyosis in combination with leiomyomas, as presented in this case report, has not been described so far. These endometrial changes are important, since they significantly contribute to infertility.

间隔子宫是一种畸形引起的吸收缺陷的勒氏管。它可能是不完整的,或者——不太常见——完整的。我们提出一个完全子宫隔的病例,特别强调子宫内膜的改变。我们描述了一个46岁的女性患者(无孕)与已知子宫间隔的痛苦痛经。超音波显示子宫大量增大并有几个淋巴结。切除子宫,常规处理组织标本。镜下检查发现1 230克重的子宫完全隔。特别是肌层增大,呈囊性切面,有几个结节,直径达4.5 cm。组织学上,我们发现明显的子宫腺肌病伴几个平滑肌瘤。已知子宫畸形患者患有子宫内膜功能障碍,最常见的原因是子宫内膜异位症。然而,本病例报告中出现的大量子宫腺肌病合并平滑肌瘤,迄今尚未见报道。这些子宫内膜变化是重要的,因为它们显著地导致不孕。
{"title":"[Massive adenomyosis in a patient with uterus septus completus].","authors":"T Hansen,&nbsp;S Wulgaris,&nbsp;W Siggelkow,&nbsp;H Kölbl,&nbsp;C J Kirkpatrick","doi":"10.1055/s-2005-836818","DOIUrl":"https://doi.org/10.1055/s-2005-836818","url":null,"abstract":"<p><p>Septate uterus is a malformation caused by the defective resorption of the Müllerian ducts. It may be incomplete, or -- less frequently -- complete. We present a case of a uterus septus completus with special emphasis on the endometrial changes. We describe a 46-year-old female patient (nullipara) with a known uterus septus suffering from hypermenorrhea. Sonography demonstrated a massively enlarged uterus with several nodes. Hysterectomy was performed and tissue specimens were routinely processed. Macroscopical examination revealed a 1 230 g-weight uterus septus completus. In particular, the myometrium was enlarged and exhibited a cystic cut surface with several nodes measuring up to 4.5 cm. Histologically, we found prominent adenomyosis with several leiomyomas. Patients with uterine malformations are known to suffer from endometrial dysfunction, most commonly due to endometriosis. However, massive adenomyosis in combination with leiomyomas, as presented in this case report, has not been described so far. These endometrial changes are important, since they significantly contribute to infertility.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 3","pages":"153-6"},"PeriodicalIF":0.0,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2005-836818","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26073955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Zentralblatt fur Gynakologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1